Loading
Total declarations
Company
▲ Purchases (13 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Jan 2019 for International Stem Cell CORP, €923k. Read the official filing
Filing timeline
BuySaleAndrey Semechkin
Insider track record
Disclosed buys
13
Disclosed sells
0
Signal history
Closed purchases
Market purchases
13
Positive at T+90
0%
Median T+90
-23.5%
Based on 12 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -32.7%Entry US$1.56 · Close at T+365 US$1.05
- +0.7%Entry US$1.49 · Close at T+365 US$1.50
- -8.5%Entry US$1.65 · Close at T+365 US$1.51
- -2.0%Entry US$1.53 · Close at T+365 US$1.50
- -9.5%Entry US$1.68 · Close at T+365 US$1.52
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Andrey Semechkin: trading record in brief
This profile gathers the share dealings of Andrey Semechkin in International Stem Cell Corp. In total, 15 filings cover trades dated from 29 June 2016 to 21 January 2019.
No open-market sale appears; the market trades are 13 purchases worth €5.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 option exercises. In 2019 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €10k. The 12 purchases reviewed show no overlap with other insiders buying the same stock within a month. Ninety days after publication, 12 purchases show a median change of -23.5%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.
The record was last updated on 22 January 2019 with an open-market purchase (€923k) in International Stem Cell Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andrey Semechkin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
599,222 shares@ US$1.7595.8% of flowCommon StockSEC:0001683168-19-000172:0
Canonical exit: 21 Apr 2019 (T+90)
30,556 shares@ US$1.091.1% of flowCommon StockSEC:0001683168-18-000493:0
15,556 shares@ US$1.100.6% of flowCommon StockSEC:0001683168-18-000493:1
1,860,810 shares@ US$1.75Common StockSEC:0001683168-17-003263:0
Canonical exit: 7 Mar 2018 (T+90)
3,200 shares@ US$1.640.2% of flowCommon StockSEC:0001683168-17-001394:0
Canonical exit: 20 Aug 2017 (T+90)
6,500 shares@ US$1.660.4% of flowCommon StockSEC:0001683168-17-000638:0
Canonical exit: 18 Jun 2017 (T+90)
500 shares@ US$1.600.0% of flowCommon StockSEC:0001683168-17-000638:1
Canonical exit: 19 Jun 2017 (T+90)
3,000 shares@ US$1.690.2% of flowCommon StockSEC:0001683168-17-000638:2
Canonical exit: 20 Jun 2017 (T+90)
5,000 shares@ US$1.320.3% of flowCommon StockSEC:0001683168-17-000559:0
Canonical exit: 8 Jun 2017 (T+90)
1,000 shares@ US$1.500.1% of flowCommon StockSEC:0001683168-17-000559:1
Canonical exit: 11 Jun 2017 (T+90)
2,100 shares@ US$1.590.1% of flowCommon StockSEC:0001683168-17-000559:2
Canonical exit: 12 Jun 2017 (T+90)
285,714 shares@ US$1.7519.8% of flowCommon StockSEC:0001683168-16-000887:0
Canonical exit: 8 Mar 2017 (T+90)
200,000 shares@ US$1.7513.3% of flowCommon StockSEC:0001683168-16-000122:0
Canonical exit: 13 Dec 2016 (T+90)
154,285 shares@ US$1.7510.2% of flowCommon StockSEC:0001019687-16-007344:0
Canonical exit: 20 Nov 2016 (T+90)
215,000 shares@ US$1.7514.4% of flowCommon StockSEC:0001019687-16-006815:0
Canonical exit: 27 Sept 2016 (T+90)
15 of 15 declarations
